about
Mutations in KERA, encoding keratocan, cause cornea planaLow density lipoprotein receptor-related protein 5 (LRP5) mutations and osteoporosis, impaired glucose metabolism and hypercholesterolaemiaThe IC3D classification of the corneal dystrophiesPrognostication in eye cancer: the latest tumor, node, metastasis classification and beyondIC3D classification of corneal dystrophies--edition 2Mitochondrial encephalomyopathy and retinoblastoma explained by compound heterozygosity of SUCLA2 point mutation and 13q14 deletion.Functional and anatomic outcome of retinal detachment surgery in pseudophakic eyes.Retinal breaks before and after neodymium:YAG posterior capsulotomy.Infiltrating macrophages in extratumoural tissues after brachytherapy of uveal melanoma.Retinal breaks and detachment after neodymium: YAG laser posterior capsulotomy: five-year incidence in a prospective cohort.Retinal detachment in pseudophakic eyes with and without Nd:YAG laser posterior capsulotomy.Scanning laser Doppler flowmetry shows reduced retinal capillary blood flow in CADASIL.Exfoliation syndrome in Nordic countries: a comparative histopathological study of Danish and Finnish eyes with absolute glaucoma and uveal melanoma.Sturge-Weber syndrome: decrease in intraocular pressure after transpupillary thermotherapy for diffuse choroidal haemangioma.Mechanisms of myopia in Cohen syndrome mapped to chromosome 8q22.Mutations in CTC1, encoding the CTS telomere maintenance complex component 1, cause cerebroretinal microangiopathy with calcifications and cysts.Sebaceous carcinoma of the eyelid associated with retinoblastoma.Red laser cyclophotocoagulation in the treatment of secondary glaucoma in eyes with uveal melanoma.Trilateral retinoblastoma: a systematic review and meta-analysis.The Incidence of Trilateral Retinoblastoma: A Systematic Review and Meta-Analysis.Pieter Pauw's tumor oculorum: reappraisal of the presumed first description of retinoblastoma in 1597.Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.Cerebroretinal microangiopathy with calcifications and cysts.A prognostic model and staging for metastatic uveal melanoma.Mode of presentation and time to treatment of uveal melanoma in FinlandThe Zimmerman-McLean-Foster hypothesis: 25 years laterPredicted Trends in the Incidence of Retinoblastoma in the Asia-Pacific Region.Simultaneous bilateral cataract surgery: a retrospective survey.Neuronal and glial properties of a murine transgenic retinoblastoma model.Microvascular loops and networks in uveal melanoma.The collaborative ocular melanoma study.Prognosis of conjunctival melanomas in relation to histopathological features.Clinically successful contact transscleral krypton laser cyclophotocoagulation. Long-term histopathologic and immunohistochemical autopsy findings.Visual outcome of eyes with malignant melanoma of the uvea after ruthenium plaque radiotherapy.Immunohistochemical analysis of lattice corneal dystrophies types I and II.Potential Effect of Tumor Necrosis Factor Inhibitors on Trabeculectomy With Mitomycin C for Patients With Juvenile Idiopathic Arthritis-Related Uveitic Glaucoma: A Retrospective Analysis.Nucleolar diameter and microvascular factors as independent predictors of mortality from malignant melanoma of the choroid and ciliary body.Carnitine palmitoyltransferase I and Acyl-CoA dehydrogenase 9 in retina: insights of retinopathy in mitochondrial trifunctional protein defects.BAP1 Germline Mutations in Finnish Patients with Uveal Melanoma.The Pediatric Choroidal and Ciliary Body Melanoma Study: A Survey by the European Ophthalmic Oncology Group.
P50
Q22254060-015CD501-E40D-4D92-97E9-77145DD70108Q24323976-405EEF5D-324F-4F13-80E1-C0CEC238238FQ24625598-526B6E24-96D3-4E44-BB86-87B38A527624Q27021793-A788C6C4-69CE-4B1D-98AB-A5802AC46112Q28255016-FC91FE7E-2C97-43B1-B5A1-4249D36415E7Q30834586-811379EC-8760-44EA-B36D-E9AF497758DEQ30840458-846419E7-A356-42E1-BD5E-76F0443E1AABQ30930817-822D0C58-F30A-4AEA-B8B1-917350FBE0B1Q30988663-9F75ED55-784A-4951-A060-20CBCC1A3340Q31048177-79212FA2-4F9B-4F6B-9632-2523F808ACA5Q31974296-1CA69A29-3162-4AD4-9C88-36FE3E772CC5Q33207744-C27AA65F-5D96-4452-91C5-B0AD79FFA3CEQ33231038-17BD6D9A-BDE7-4E7A-BA86-03F204B9E404Q33521085-43961AA0-0F78-48B1-9E0F-7F27ED11EF17Q34125910-23C50AA3-CAE8-4EFE-9D19-9AF180B187E2Q34258372-1CD4DE48-F886-4EA2-A031-8E0979A2BAA8Q34267692-5908AB76-EBE9-4E51-A4AD-AC25E322DF27Q34307116-8678E265-5C9D-4FF0-919E-5239CB1990E6Q34433758-A50F9715-AC83-4EC0-A06A-F6E2BCCD1037Q34494341-1E590BA6-A5C5-481E-8304-E455562C9973Q34534326-40EB34EB-6467-4EC2-B26F-4194F4C92AADQ34543047-E2C0BE44-CDB9-4855-A825-964470DA4F72Q34561957-FD6B0CF1-90AD-4AA0-8418-5D7A055BD7EAQ35041322-F1D5137A-36AB-4D6C-BD6D-62D312761E09Q35589470-D812F6CC-E205-4C87-ADBF-8A337A266F33Q35592261-18B2C8A0-11FD-4724-B6E9-5BCCEA80A43FQ35673006-56ECDC82-AAFE-427F-BF5A-A05AA18426E7Q35792361-4628E7E3-86EA-420E-A301-8CF290E2FAB1Q35830265-3796F368-CC33-4B29-AA10-35AA8BCB0F09Q35870258-6BB5A1F4-51E6-4EE8-903C-76442908CCE5Q36068925-00E12D39-4D21-4F75-9464-C4D948AF2FD2Q36467045-0230E5A6-99A4-4082-93D9-4D6A4FE8D3AEQ36670971-7BF71761-86F8-4486-B0C3-BC50A0707674Q36837846-8F99F182-049E-452D-88E3-4B92A8082F30Q37304076-9C764D00-775B-47A6-B973-6ECE8EF90278Q38960477-60CFA920-DDD7-4A72-AC0E-0CF0089C3A86Q39650302-60052F58-0039-43D6-8CB7-7420582CAAF1Q39995623-E357CC3F-607B-495A-83E6-3C5F9080497BQ39997349-9C4DDC68-BACB-49BC-B50F-72DF50EB5C7CQ40016055-287273BF-4C9C-45B0-90DC-71FF6BF15B88
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Tero Kivelä
@ast
Tero Kivelä
@en
Tero Kivelä
@es
Tero Kivelä
@nl
Tero Kivelä
@sl
type
label
Tero Kivelä
@ast
Tero Kivelä
@en
Tero Kivelä
@es
Tero Kivelä
@nl
Tero Kivelä
@sl
prefLabel
Tero Kivelä
@ast
Tero Kivelä
@en
Tero Kivelä
@es
Tero Kivelä
@nl
Tero Kivelä
@sl
P106
P1153
7006765313
P21
P31
P496
0000-0003-1198-4394
P569
2000-01-01T00:00:00Z